novo nordisk semaglutide vial withdraws FDA application to expand use of weight loss drug Shares in Danish drugmaker Novo

This allows PlexusDx to offer semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plansignificantly lower than brand-name alternatives that often cost $900-$1,300 monthly

PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies your genetic predisposition to GLP-1 sensitivity through variants like GLP1R rs6923761, helping your provider personalize your starting dose and escalation schedule to minimize this particular side effect

This clinically studied ingredient has been shown in human clinical studies to support visceral fat loss, reduce body mass index (BMI), and improve body composition

, e020180

Among the millions of Byetta prescriptions written since 2005, fewer than 80,000 total cases have resulted in adverse events